IG Group Cuts 2026 Revenue Outlook After OTC Weakness

IG Group cut its 2026 revenue-growth outlook on October 2 after weaker retention in its over-the-counter derivatives business weighed on third-quarter revenue, prompting a sharp fall in its shares. The London-based trading company said it now expects revenue growth in the mid-single-digit percentage range for the year, rather than growth toward the upper end of its previous mid-to-high single-digit target range. IG estimated total revenue at about £240 million for the three months ended September 30, down roughly 14% from £280.1 million in the same period a year earlier. The figures were estimates in a trading update, not final reported results. IG attributed the decline to weaker OTC revenue retention amid less supportive market conditions. Retention was about 70% in the quarter, compared with an average of around 80% since the second half of 2025, when the company introduced market-making optimisation measures. IG said it remained confident those measures would increase retention over the medium to long term, while warning of greater short-term variability. The company also reported signs of growth in customer activity.